文章核心观点 - ICU Medical在2026年9月止季度实现营收5.5622亿美元，同比增长4.3%，超出Zacks共识预期的5.5315亿美元，意外惊喜为+0.55% [1] - 同季度每股收益为2.44美元，相比去年同期的2.03美元有所提升，超出共识预期的2.14美元，EPS意外惊喜达+14.02% [1] - 投资者除关注营收和盈利的同比变化及与华尔街预期的比较外，部分关键指标能更好揭示公司底层经营表现，将这些指标与去年同期及分析师预期对比有助于更准确预测股价表现 [2] - ICU Medical股价过去一个月回报率为+10.6%，而Zacks标普500综合指数同期变化为-0.4% [3] 分项业务营收表现 - 输液系统业务营收为1.925亿美元，高于两位分析师平均预期的1.8397亿美元 [4] - Vital Care业务营收为6950万美元，低于两位分析师平均预期的7709万美元 [4] - 耗材业务营收为2.984亿美元，高于两位分析师平均预期的2.962亿美元 [4]

文章核心观点 - 文档内容为浏览器技术提示信息，要求启用Javascript和cookies以确保正常访问，并提示广告拦截器可能导致访问被阻止，需禁用广告拦截器并刷新页面 [1] - 文档未包含任何关于公司、行业、财务数据、市场事件或投资机会与风险的实际新闻内容 [1] 相关目录总结 - 文档中不存在可归入行业研究、公司研究、财报解读、新闻事件分析等任何投研相关目录的内容 [1] - 文档未提供任何数字数据、百分比变化或金额单位信息（billion、million、thousand）[1]

ICU Medical (NasdaqGS:ICUI) Q3 2026 Earnings call November 05, 2026 04:30 PM ET Company Participants Deirdre Thomson - SVP of Investor Relations Vivek Jain - CEO and Chairman Brian Bonnell - CFO Conference Call Participants Jayson Bedford - Analyst Larry Solow - Analyst None - Analyst Brett Fishbin - Analyst Mike Matson - Analyst Sam Eiber - Analyst Operator Good afternoon, everyone, and welcome to today's ICU Medical Inc Third Quarter 2026 Earnings Conference Call. All participants will be in listen-only m ...

ICU Medical (NasdaqGS:ICUI) Q3 2026 Earnings call November 05, 2026 04:30 PM ET Speaker0Good afternoon, everyone, and welcome to today's ICU Medical Inc. third quarter 2026 earnings conference call. All participants will be in listen-only mode. After today's presentation, there will be an opportunity to ask questions. To ask a question at that time, please press star one. Also, please note that today's event is being recorded. I'd now like to turn the conference over to Deirdre Thomson, ICR Senior Vice Pres ...

For the transition period from: to UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2026 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No.: 001-34634 ICU MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 33-0022692 (State or other jurisdiction of (I.R ...

Exhibit 99.1 ICU Medical Announces Third Quarter 2026 Results and Reaffirms Fiscal Year 2026 Guidance, Expecting Results at the High End of Range SAN CLEMENTE, Calif., November 5, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2026. Third Quarter 2026 Results Third quarter 2026 GAAP revenue was $560.4 million, as compared to $537.0 millio ...

SAN CLEMENTE, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended September 30, 2026. Third Quarter 2026 Results Third quarter 2026 GAAP revenue was $560.4 million, as compared to $537.0 million in the same period in the prior year. GAAP gross profit for the third quarter of 2026 was $234.8 million, as compared to $200.9 million in the same ...